Blar i forfatter Det helsevitenskapelige fakultet "Hallan, Geir"

Viser treff 1-2 av 2

    • Antibiotic-loaded bone cement in prevention of periprosthetic joint infections in primary total knee arthroplasty: A register-based multicentre randomised controlled non-inferiority trial (ALBA trial) 

      Leta, Tesfaye Hordofa; Gjertsen, Jan-Erik; Dale, Håvard; Hallan, Geir; Lygre, Stein Håkon Låstad; Fenstad, Anne Marie; Dyrhovden, Gro Sævik; Westberg, Marianne; Wik, Tina Strømdal; Jakobsen, Rune Bruhn; Aamodt, Arild; Röhrl, Stephan Maximillian; Gøthesen, Øystein Johannes; Lindalen, Einar; Heir, Stig; Ludvigsen, Jarle; Bruun, Trond; Hansen, Ann Kristin; Aune, Knut Erik Moen; Warholm, Marianne; Skjetne, John Petter; Badawy, Mona; Høvding, Pål; Husby, Otto Schnell; Karlsen, Øystein Espeland; Furnes, Ove Nord (Journal article; Tidsskriftartikkel; Peer reviewed, 2021-01-28)
      <i>Introduction</i> - The current evidence on the efficacy of antibiotic-loaded bone cement (ALBC) in reducing the risk of periprosthetic joint infections (PJI) after primary joint reconstruction is insufficient. In several European countries, the use of ALBC is routine practice unlike in the USA where ALBC use is not approved in low-risk patients. Therefore, we designed a double-blinded pragmatic ...

    • The Delta III and Delta Xtend reverse shoulder arthroplasty. Risk of revision and failure mechanisms: a report on 3,650 cases from the Norwegian Arthroplasty Register 1994-2021 

      Hole, Randi Margrete; Fenstad, Anne Marie; Gjertsen, Jan-Erik; Hallan, Geir; Furnes, Ove Nord (Journal article; Tidsskriftartikkel; Peer reviewed, 2023-12-15)
      Background - The Delta reverse shoulder arthroplasty (RSA) is commonly used worldwide and is the most frequently used RSA in Norway. The aim of this registry-based study was to report 10- and 20-year implant survival, risk of revision, and reasons for revision in 2 consecutive time periods for Delta III (1994-2010) and Delta Xtend (2007-2021) prostheses.<p> <p>Methods - We included 3650 primary ...